Cargando…

Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?

According to the World Health Organization (WHO), Plasmodium falciparum malaria during pregnancy is responsible for deleterious consequences for the mother and her child. The administration of intermittent preventive treatment (IPTp) with sulfadoxine–pyrimethamine (SP) at each antenatal care visit a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaillard, Tiphaine, Boxberger, Manon, Madamet, Marylin, Pradines, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295070/ https://www.ncbi.nlm.nih.gov/pubmed/30547849 http://dx.doi.org/10.1186/s12936-018-2621-x

Ejemplares similares

The end of a dogma: the safety of doxycycline use in young children for malaria treatment
por: Gaillard, Tiphaine, et al.
Publicado: (2017)

Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
por: Foguim Tsombeng, Francis, et al.
Publicado: (2019)

Tetracyclines in malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2015)

Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2016)

Malaria Prophylaxis Failure with Doxycycline, Central African Republic, 2014
por: Madamet, Marylin, et al.
Publicado: (2015)

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
por: Foguim, Francis Tsombeng, et al.
Publicado: (2020)

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?
por: Gaillard, Tiphaine, et al.
Publicado: (2016)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
por: Gendrot, Mathieu, et al.
Publicado: (2018)

Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs
por: Foguim, Francis Tsombeng, et al.
Publicado: (2019)

PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2013)

Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline
por: Gaillard, Tiphaine, et al.
Publicado: (2015)

Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
por: Fall, Bécaye, et al.
Publicado: (2016)

Plasmodium falciparum proteome changes in response to doxycycline treatment
por: Briolant, Sébastien, et al.
Publicado: (2010)

Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014
por: Voumbo-Matoumona, Dominique Fatima, et al.
Publicado: (2018)

Prevalence of Mutations in the pfcoronin Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against Plasmodium falciparum
por: Delandre, Océane, et al.
Publicado: (2021)

Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient
por: Roseau, Jean Baptiste, et al.
Publicado: (2016)

Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015
por: Diawara, Silman, et al.
Publicado: (2017)

Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges
por: Ishengoma, Deus S., et al.
Publicado: (2019)

Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum
por: Gendrot, Mathieu, et al.
Publicado: (2021)

Assessment of a Commercial Real-Time PCR Assay (Vitassay qPCR Malaria 5 Test) to Detect Human Malaria Infection in Travelers Returning to France
por: Madamet, Marylin, et al.
Publicado: (2022)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
por: Gendrot, Mathieu, et al.
Publicado: (2022)

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2014)

Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013–2014 malaria season
por: Fall, Bécaye, et al.
Publicado: (2015)

THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912)

Global response of Plasmodium falciparum to hyperoxia: a combined transcriptomic and proteomic approach
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2011)

Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014
por: Boussaroque, Agathe, et al.
Publicado: (2016)

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
por: Pascual, Aurélie, et al.
Publicado: (2013)

Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2011)

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010)

How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?
por: Sutherland, Colin J, et al.
Publicado: (2007)

Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle
por: Stallmach, Robert, et al.
Publicado: (2015)

Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013–2018
por: Joste, Valentin, et al.
Publicado: (2021)

Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs
por: Fall, Bécaye, et al.
Publicado: (2011)

Systems Analysis of Chaperone Networks in the Malarial Parasite Plasmodium falciparum
por: Pavithra, Soundara Raghavan, et al.
Publicado: (2007)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs
por: Pascual, Aurélie, et al.
Publicado: (2011)

Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_u1e4pdqjb6eu5tds1nqg512cj5